M Zerbib

Summary

Country: France

Publications

  1. ncbi request reprint [Study of intermittent endocrine therapy in patients presenting with biologic recurrence after radical prostatectomy or radiotherapy]
    Alexandre De La Taille
    Service d Urologie, CHU Cochin, Paris, France
    Prog Urol 12:240-7. 2002
  2. ncbi request reprint [Difficult clinical cases in prostate cancer: multidisciplinary staff, the rational principles of adjuvant therapy and other therapeutic options]
    M Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Urol (Paris) 40:S35-41. 2006
  3. ncbi request reprint [Management of rising PSA after total prostatectomy]
    M Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Urol (Paris) 41:S73-6. 2007
  4. ncbi request reprint [Contribution of LHRH analogs in prostate cancer treatment]
    M Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Urol (Paris) 41:S83-6. 2007
  5. pmc Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma
    Min Han Tan
    Laboratory of Cancer Genetics, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
    BMC Cancer 10:196. 2010
  6. ncbi request reprint [GnRH analogs and prostate cancer treatment]
    Marc Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75679 Paris 14, France
    Ann Urol (Paris) 39:S66-72. 2005
  7. ncbi request reprint [Synthesis of the multidisciplinary consensus meeting on prostatic cancer]
    M Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Urol (Paris) 40:S42-3. 2006
  8. doi request reprint Conventional treatments of localized prostate cancer
    Marc Zerbib
    Department of Urology, Groupe Hospitalier Cochin, Paris, France
    Urology 72:S25-35. 2008
  9. doi request reprint [Analysis of anatomopathological results of radical prostatectomy specimen of patients who answer to criteria for active surveillance of prostate cancer]
    V Azancot
    Service d Urologie, Hopital Cochin, Paris Cedex 14, France
    Prog Urol 19:619-23. 2009
  10. ncbi request reprint Intermittent androgen suppression in patients with prostate cancer
    A de la Taille
    Department of Urology, CHU Cochin, Paris, France
    BJU Int 91:18-22. 2003

Collaborators

Detail Information

Publications77

  1. ncbi request reprint [Study of intermittent endocrine therapy in patients presenting with biologic recurrence after radical prostatectomy or radiotherapy]
    Alexandre De La Taille
    Service d Urologie, CHU Cochin, Paris, France
    Prog Urol 12:240-7. 2002
    ..Study of the efficacy of intermittent endocrine therapy after failure of local treatment...
  2. ncbi request reprint [Difficult clinical cases in prostate cancer: multidisciplinary staff, the rational principles of adjuvant therapy and other therapeutic options]
    M Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Urol (Paris) 40:S35-41. 2006
    ..Immediate hormonal therapy with bicalutamide is a valuable therapeutic option in men having prostate cancer with such clinicopathological features...
  3. ncbi request reprint [Management of rising PSA after total prostatectomy]
    M Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Urol (Paris) 41:S73-6. 2007
    ..Predictive factors can differentiate Local recurrence and distant metastasis. Depending on the case, the therapeutic options for managing these recurrences are radiotherapy, hormone therapy, and chemotherapy...
  4. ncbi request reprint [Contribution of LHRH analogs in prostate cancer treatment]
    M Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Urol (Paris) 41:S83-6. 2007
    ....
  5. pmc Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma
    Min Han Tan
    Laboratory of Cancer Genetics, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
    BMC Cancer 10:196. 2010
    ..Previous studies have been relatively limited in terms of examining the differences between oncocytoma and chromophobe RCC...
  6. ncbi request reprint [GnRH analogs and prostate cancer treatment]
    Marc Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75679 Paris 14, France
    Ann Urol (Paris) 39:S66-72. 2005
    ..Combination of analogs with chemotherapy has been used very recently for patients who have reached hormonal escape and may be a useful immediate option for patients with cancers with a high risk of progression...
  7. ncbi request reprint [Synthesis of the multidisciplinary consensus meeting on prostatic cancer]
    M Zerbib
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Urol (Paris) 40:S42-3. 2006
  8. doi request reprint Conventional treatments of localized prostate cancer
    Marc Zerbib
    Department of Urology, Groupe Hospitalier Cochin, Paris, France
    Urology 72:S25-35. 2008
    ..For locally extensive cancer, androgen-deprivation therapy should be used alone only for the relief of local symptoms in men with a life expectancy of <5 years who are not eligible for more aggressive treatment...
  9. doi request reprint [Analysis of anatomopathological results of radical prostatectomy specimen of patients who answer to criteria for active surveillance of prostate cancer]
    V Azancot
    Service d Urologie, Hopital Cochin, Paris Cedex 14, France
    Prog Urol 19:619-23. 2009
    ..To analyze pathological data of the radical prostatectomy specimen in patients operated for clinically-localized prostate cancer and who meet strict criteria for active surveillance...
  10. ncbi request reprint Intermittent androgen suppression in patients with prostate cancer
    A de la Taille
    Department of Urology, CHU Cochin, Paris, France
    BJU Int 91:18-22. 2003
    ..To evaluate intermittent androgen suppression (IAS) in patients with prostate cancer and to try to define predictive factors for biochemical progression...
  11. doi request reprint [Pronostic value of ureteral location of upper tract urinary carcinoma]
    C Le Goux
    Service d Urologie, Hopital Cochin, Université Paris V Paris Descartes, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 23:399-404. 2013
    ..The aim of this study was to evaluate the prognostic significance of the ureteral location of the upper tract urinary carcinoma (UTUC)...
  12. doi request reprint Endorectal 3D T2-weighted 1mm-slice thickness MRI for prostate cancer staging at 1.5Tesla: should we reconsider the indirects signs of extracapsular extension according to the D'Amico tumor risk criteria?
    F Cornud
    Department of Radiology, Hopital Cochin, Universite Paris Descartes, France IRM Paris 16, 46 48 rue Chardon Lagache, 75116 Paris, France
    Eur J Radiol 81:e591-7. 2012
    ..To evaluate the accuracy of a 3D-endorectal 1mm-thick slices MRI acquisition for local staging of low, intermediate and high D'Amico risk prostate cancer (PCa)...
  13. doi request reprint [Testicular implants, patient's and partner's satisfaction: a questionnaire-based study of men after orchidectomy]
    E Xylinas
    Service d Urologie, Faculte de Medecine, Universite Paris Descartes, Hopital Cochin, AP HP, 75014 Paris, France
    Prog Urol 18:1082-6. 2008
    ..To assess the satisfaction of men and of their partner towards their testicular implants after undergoing orchidectomy...
  14. ncbi request reprint IL-6 is a survival prognostic factor in renal cell carcinoma
    N Thiounn
    Clinique Urologique, Hopital Cochin, Paris, France
    Immunol Lett 58:121-4. 1997
    ..016), suggesting that serum concentration of IL-6 before treatment is a marker of tumour aggressiveness rather than a predictive parameter for an immunological response...
  15. pmc Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients
    O Huillard
    Department of Medical Oncology, University Paris Descartes, Paris, France
    Br J Cancer 108:1034-41. 2013
    ..We investigated whether sarcopenia could predict early dose-limiting toxicities (DLTs) occurrence in mRCC patients treated with sunitinib...
  16. doi request reprint [Healing and targeted therapies: Management in perioperative period?]
    G Pignot
    Service d Urologie, Hopital Cochin, Universite Rene Descartes, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 21:166-72. 2011
    ....
  17. doi request reprint [Prebiopsy multiparametric MRI of the prostate: the end of randomized biopsies?]
    O Belas
    Service d Urologie, Hopital Cochin, Universite Paris Descartes, AP HP, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 22:583-9. 2012
    ..To evaluate the value of multiparametric MRI-targeted prostate biopsies in patients with suspected low-risk prostate cancer...
  18. doi request reprint [pT3N0 prostate cancer treated with radical prostatectomy as sole treatment: Oncological results and predictive factors of recurrence]
    N Barry Delongchamps
    Department of Urology, Cochin Hospital, Paris Descartes University, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 22:100-5. 2012
    ..To evaluate biological free survival in patients with locally advanced prostate cancer treated with radical prostatectomy (RP) as sole treatment, and to analyse predictive factors of recurrence...
  19. ncbi request reprint [Risk factors for positive surgical margins following radical prostatectomy: review]
    A Descazeaud
    Service d urologie de l hôpital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Ann Urol (Paris) 40:342-8. 2006
    ....
  20. ncbi request reprint [In vitro study of the modulation of human ureteral tonus by nitric oxide and zaprinast, a phosphodiesterase inhibitor]
    D Saighi
    Service d Urologie, CHU Cochin, Paris, France
    Prog Urol 10:1161-8. 2000
    ..To assess the role of nitric oxide (NO) and its second messenger, cGMP, on the mechanisms underlying human ureteral smooth muscle relaxation...
  21. ncbi request reprint [Stage T1a prostatic cancer: long-term retrospective study of 27 patients]
    A Descazeaud
    Clinique Urologique, , 27, rue du Faubourg Saint Jacques, 75014 Paris
    Prog Urol 11:662-6. 2001
    ..However, our study showed tumour progression in 25% of cases, raising the question of curative treatment, especially in young patients...
  22. doi request reprint Multiparametric MRI is helpful to predict tumor focality, stage, and size in patients diagnosed with unilateral low-risk prostate cancer
    N B Delongchamps
    Department of Urology, Cochin Hospital, Paris Descartes University, Paris, France
    Prostate Cancer Prostatic Dis 14:232-7. 2011
    ..Multiparametric MRI may therefore have a prognostic value and help to determine optimal treatment in such patients...
  23. doi request reprint [Hybrid renal tumors: a report of two patients]
    N B Delongchamps
    Service d Urologie, Hopital Cochin, Universite Paris Descartes, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 20:1223-6. 2010
    ..They have been reported in patients with Birt-Hogg-Dube (BHD) syndrome. The aim of this report was to describe two cases of HT and summarize recent literature...
  24. ncbi request reprint [Intermittent hormone therapy for prostate cancer]
    M Peyromaure
    Service d Urologie, Hopital Cochin, Paris, France
    Ann Urol (Paris) 39:116-23. 2005
    ..Prospective comparative trials are ongoing; they will determine the true benefit of intermittent hormone therapy in prostate cancer...
  25. ncbi request reprint Impact of sarcopenia (Sp) on early dose-limiting toxicity (DLT) and acute vascular toxicity in patients (pts) with metastatic renal cell carcinoma (mRCC) receiving sunitinib (SUT)
    O Huillard
    Cochin Teaching Hospital, AP HP, Paris Descartes University, Paris, France Necker Teaching Hospital, AP HP, Paris Descartes University, Paris, France
    J Clin Oncol 29:e15094. 2011
    ..e15094 Background: mRCC pts with severe muscle wasting (Sp) are at increased risk of DLT during anti-VEGF therapy with sorafenib (Antoun et al., Ann Oncol 2010). We hypothesized that Sp could also predict SUT-induced toxicity...
  26. pmc Hedgehog pathway activation in human transitional cell carcinoma of the bladder
    G Pignot
    Department of Urology, Service d Urologie, Universite Paris Descartes, Sorbonne Paris Cité, 27 rue du Faubourg Saint Jaques, Paris F 75014, France
    Br J Cancer 106:1177-86. 2012
    ..The Hedgehog (Hh) signalling pathway functions as an organiser in embryonic development. Recent studies have shown constitutive activation of this pathway in various malignancies, but its role in bladder cancer remains poorly studied...
  27. doi request reprint [Spermatic cord sarcoma in adults: diagnosis and management]
    C Kanso
    Service d Urologie, Hopital Cochin, Universite Paris Descartes, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 21:53-8. 2011
    ..to clarify the patterns of diagnosis and management of adult spermatic cord sarcoma...
  28. doi request reprint [Use of double J ureteral stent as an alternative to prevent ureteroileal anastomosis stricture in orthotopic bladder substitution]
    H Echo
    Service d Urologie, Hopital Cochin, Groupe Hospitalier Cochin St Vincent de Paul, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 19:127-31. 2009
    ..The aim of the study was to compare ureteroileal anastomosis strictures rates in patients receiving either double J stent or open-ended ureteral stent, after bladder replacement for cancer...
  29. doi request reprint [PTa bladder tumours: prognostic factors of recurrence and progression]
    G Martinache
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 18:35-40. 2008
    ..The aim of this work has been to study the prognostic factors of recurrence and progression of stage pTa bladder tumours...
  30. doi request reprint [Pronostic value of parenchyma renal invasion of pT3 upper tract urinary carcinoma]
    M Bruzzi
    Service d Urologie, Hopital Bicetre, université Paris Sud Paris XI, 94270 Le Kremlin Bicetre, France
    Prog Urol 24:556-62. 2014
    ..The aim of this study was to evaluate the prognostic significance of these three different groups of pT3 tumors...
  31. doi request reprint [Intra-prostatic UroLift(®) implants for benign prostatic hyperplasia: preliminary results of the four first cases performed in France]
    N B Delongchamps
    Service d Urologie, Universite Paris Descartes, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 22:590-7. 2012
    ..To evaluate the feasibility, tolerance and short-term efficacy of intra-prostatic UroLift(®) implants in four patients with symptomatic benign prostatic hyperplasia...
  32. ncbi request reprint Predictive factors of radiation therapy for patients with prostate specific antigen recurrence after radical prostatectomy
    A de la Taille
    Department of Urology, CHU Cochin, and Department of Radiotherapy, Institut Curie, Paris, France
    BJU Int 90:887-92. 2002
    ..To assess the efficacy of salvage/adjuvant radiation therapy (RT) for patients with prostate-specific antigen (PSA) recurrence after radical prostatectomy (RP)...
  33. doi request reprint [Primary metastatic urethral melanoma: a case study]
    M Gassara
    Service d Urologie, Hopital Cochin, Universite Paris Descartes, Paris, France
    Prog Urol 20:80-2. 2010
    ..Primary urethral melanoma is a rare pathology for which treatment strategies are controversial. The aim of this work was to report a case of metastatic primary urethral melanoma, and to discuss recent data available from literature...
  34. doi request reprint [Prostate cancer: medicoeconomic aspects]
    C Kanso
    Service d Urologie, Hopital Cochin, Universite Paris Descartes, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 20:85-90. 2010
    ..The indirect costs of prostate cancer concern the loss of economic production associated with the disease and death and are more difficult to determine...
  35. ncbi request reprint Management of a malignant urinary fistula by ureteral embolization with coils
    Delphine Amsellem-Ouazana
    Department of Urology, Hopital Cochin, Paris, France
    Urology 68:427.e1-3. 2006
    ..Using the percutaneous access already in place, we performed bilateral ureteral embolization with coils. Complete ureteral occlusion was obtained with a minimally invasive procedure and allowed total symptomatic relief...
  36. doi request reprint [Negative prognostic impact of female gender on oncological outcomes following radical cystectomy]
    Y Dabi
    Service d Urologie, Hopital Cochin, Universite Paris Descartes, Assistance Publique Hopitaux de Paris, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Prog Urol 26:83-8. 2016
    ..To confirm gender specific differences in pathologic factors and survival rates of urothelial bladder cancer patients treated with radical cystectomy...
  37. doi request reprint Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder
    E Xylinas
    Department of Urology, Weill Cornell Medical College, New York, NY, USA Inserm U955 Equipe 07, Université Paris Est Créteil, Creteil, France Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France
    Eur J Surg Oncol 40:121-7. 2014
    ..Expression of T-cell co-regulatory proteins has been associated with worse outcomes in patients with UCB. We aimed to confirm these findings...
  38. pmc Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder
    E Xylinas
    1 Department of Urology, Weill Cornell Medical College, New York, NY, USA 2 Department of Urology, Cochin Hospital, APHP, Paris Descartes University, Paris, France
    Br J Cancer 109:1460-6. 2013
    ..The aim of the current study was to assess the performance of these predictive tools in a large multicentre cohort of NMIBC patients...
  39. ncbi request reprint Corporeal plication for surgical correction of penile curvature. Experience with 60 patients
    N Thiounn
    Clinique Urologique de l Hôpital Cochin, Paris, France
    Eur Urol 33:401-4. 1998
    ..To evaluate the efficacy of tunica albuginea plication without excision in patients with congenital and acquired penile curvature...
  40. ncbi request reprint T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival
    M Peyromaure
    Department of Urology, Cochin Hospital, Paris, France
    BJU Int 93:60-3. 2004
    ..To report our experience with T1G3 bladder tumours over the last 10 years...
  41. ncbi request reprint [Chromophobe cell renal cancer, a distinct entity. Report of a series of 35 cases]
    M Peyromaure
    Service d'Urologie, , Paris, France
    Prog Urol 11:209-14; discussion 214-6. 2001
    ..This tumour appears to have a good prognosis, as it is usually confined to the kidney with a low nuclear grade...
  42. ncbi request reprint [Sexual function after radical prostatectomy does not affect global patient satisfaction]
    Aurelien Descazeaud
    Service d Urologie, Hopital Cochin, Paris, France
    Prog Urol 14:1177-80. 2004
    ..To evaluate the quality of life after retropubic radical prostatectomy (RP) and its impact on global patient satisfaction concerning the treatment received...
  43. ncbi request reprint Can pT0 stage of prostate cancer be predicted before radical prostatectomy?
    Aurelien Descazeaud
    Department of Urology, Cochin Hospital, Paris, France
    Eur Urol 50:1248-52; discussion 1253. 2006
    ..To report our experience with biopsy-proven pT0 prostate cancer over the last 10 yr...
  44. ncbi request reprint Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence
    Nicolas B Delongchamps
    Department of Urology, Cochin Hospital, Descartes University, Paris, France
    Can J Urol 16:4813-9. 2009
    ..This study aimed to evaluate oncological results of three-dimensional conformal RT (3D-CRT) in patients who had biochemical recurrence...
  45. ncbi request reprint [The low weight of the prostate is an independent risk factor for positive surgical margins on radical prostatectomy specimens]
    Aurelien Descazeaud
    Service d Urologie, Hopital Cochin, Paris
    Prog Urol 17:203-7. 2007
    ..The presence of positive surgical margins (PSM) on radical prostatectomy specimen is predictive of biological recurrence. Our objective was to analyze the influence of prostate weight on surgical margins status after radical prostatectomy...
  46. ncbi request reprint Evolution of health-related quality of life two to seven years after retropubic radical prostatectomy: evaluation by UCLA prostate cancer index
    Aurelien Descazeaud
    Department of Urology, Service d Urologie, Hopital Cochin, Paris, France
    World J Urol 23:257-62. 2005
    ..Although sexual, urinary and bowel scores seem to remain stable from 2 to 7 years following RP, general health appears to significantly deteriorate with time after RP, independent of the patient's age at the time of the questionnaire...
  47. doi request reprint [New concepts in the management of MIBC in 2010]
    G Pignot
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75679 Paris Cedex 14, France
    Prog Urol 21:S38-42. 2011
    ..Only some patients can hope a complete response after neoadjuvant chemotherapy. For these responders, we can sometimes discuss, at an individual level, a bladder conservative strategy with an intensive surveillance...
  48. ncbi request reprint [Urologic complications of radiotherapy]
    A de la Taille
    Service d Urologie, CHU Henri Mondor, 54, boulevard du Général de Lattre de Tassigny, 94000 Creteil, France
    Ann Urol (Paris) 37:345-57. 2003
    ....
  49. ncbi request reprint [Cystine lithiasis: study of a series of 116 cases]
    F Kirsch-Noir
    Service d Uro Andrologie, Hopital Tenon, Paris, France
    Prog Urol 10:1135-44. 2000
    ..Cystine stones is a rare disease, related to a genetic metabolic disease. Its management must treat both the stones and their complications, and prevent recurrences by controlling cystinuria...
  50. ncbi request reprint Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study
    Delphine Amsellem-Ouazana
    Department of Urology, Hopital Cochin, Service d Urologie, 27, rue du Faubourg Saint Jacques, 75014 Paris, France
    Eur Urol 47:582-6. 2005
    ..The aim of this study was to evaluate the use of combined MRI and magnetic resonance spectroscopy imaging (MRSI) for these patients...
  51. ncbi request reprint [Treatment of biological recurrence after treatment of localized prostatic cancer]
    Marc Zerbib
    Hopital Cochin, Paris
    Prog Urol 14:19-21. 2004
  52. ncbi request reprint Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer
    Nicolas Barry Delongchamps
    Department of Urology, Cochin Hospital, Service d Urologie, Paris, France
    Eur Urol 48:946-50. 2005
    ..To analyze the outcome of patients after fortuitous diagnosis of prostate cancer (PCa) on cystoprostatectomy (CPT) specimen...
  53. ncbi request reprint [UCLA/RAND Cancer Prostate Index quality of life questionnaire after external beam radiotherapy for localized prostate cancer: repercussions of complications and quality of life in general]
    Christophe Almeras
    Clinique Urologique, Hopital Cochin, Paris, France
    Prog Urol 13:256-65. 2003
    ..This study was designed to evaluate the quality of life after external beam radiotherapy for localized prostate cancer using the UCLA/RAND Cancer Prostate Index questionnaire...
  54. ncbi request reprint Salvage radiotherapy for biochemical recurrence after radical prostatectomy: a study of 62 patients
    Michael Peyromaure
    Department of Urology, Cochin Hospital, Paris, France
    Urology 62:503-7. 2003
    ..To determine the predictive factors of prostate-specific antigen (PSA) recurrence after salvage radiotherapy (RT) for biochemical recurrence following radical prostatectomy (RP) to identify patients who may benefit from this treatment...
  55. ncbi request reprint [Prostate cancer incidence on specimen of cystoprostatectomy for infiltrative bladder cancer]
    Marc Zerbib
    Service d Urologie, Hopital Cochin, Paris, France
    Prog Urol 15:1262-5. 2005
  56. ncbi request reprint [GnRH analogues in the treatment of prostate cancer]
    Marc Zerbib
    Clinique Urologique, Hopital Cochin, Paris
    Rev Prat . 2005
  57. ncbi request reprint [Nadir PSA and kinetics of PSA decline between the 3rd and 6th month after external beam radiotherapy for T1 T2 Nx M0 localized prostate cancer: value of the prediction of the risk of biological progression]
    Christophe Almeras
    Clinique Urologique, Hopital Cochin, Paris, France
    Prog Urol 12:219-25. 2002
    ..This study analyses the results of external beam radiotherapy in stage T1 T2 Nx M0 prostate cancer, with reference to the nadir PSA and the kinetics of PSA decline...
  58. ncbi request reprint [Does transrectal MRI before radical prostatectomy modify the operative technique to decrease the positive margin rate?]
    Aurelien Descazeaud
    Service d Urologie, Hopital Cochin, Paris, France
    Prog Urol 16:564-7. 2006
    ..To determine the value of magnetic resonance imaging (MRI) in the surgical management of prostate cancer patients...
  59. ncbi request reprint Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era
    Aurelien Descazeaud
    Department of Urology, Cochin Hospital, Paris, France
    Eur Urol 53:355-61. 2008
    ..The aim of our study was to determine the predictive factors of progression in patients with T1a prostate cancer diagnosed in the PSA era...
  60. ncbi request reprint Intermittent androgen deprivation for biologic recurrence after radical prostatectomy: long-term experience
    Michael Peyromaure
    Department of Urology, Cochin Hospital, Paris, France
    Urology 65:724-9. 2005
    ..To analyze the oncologic results of intermittent androgen deprivation (IAD) for biochemical recurrence after radical prostatectomy (RP)...
  61. ncbi request reprint Concurrent chemoradiotherapy for clinical stage T2 bladder cancer: report of a single institution
    Michael Peyromaure
    Department of Urology, Cochin Hospital, Paris, France
    Urology 63:73-7. 2004
    ..To report our experience with concurrent chemoradiotherapy for clinical Stage T2 bladder cancer...
  62. ncbi request reprint [Treatments in invasive bladder cancer]
    Olivier Bouchot
    Clinique Urologique, CHU Hotel Dieu, Nantes, France
    Prog Urol 13:1415-27. 2003
    ....
  63. ncbi request reprint [Anaemia and prostatic cancer]
    Rania Boustany
    Departement de Radiotherapie, Institut Gustave Roussy, Villejuif, France
    Prog Urol 15:604-10. 2005
    ..Furthermore, as treatment of advanced disease is based on symptomatic treatment and improvement of quality of life, correction of anaemia must also be considered as part of palliative care...
  64. ncbi request reprint [Prostatic invasion and indications for urethra surgery]
    Marc Zerbib
    Prog Urol 12:923-30. 2002
  65. ncbi request reprint Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients
    Michael Peyromaure
    Department of Urology, Hopital Cochin, Paris, France
    J Urol 169:2110-2. 2003
    ..We report our experience with stage T1 grade 3 bladder tumors treated with bacillus Calmette-Guerin (BCG) therapy in the last 10 years...
  66. ncbi request reprint [Testicular germ cell tumors: prognosis]
    Makram Miladi
    Service d Urologie, Hopital Cochin, 27, rue du Faubourg Saint Jacques, 75014 Paris
    Prog Urol 13:92-7. 2003
    ..To assess the prognosis of germ cell tumours of the testis based on a series of 60 patients...
  67. ncbi request reprint [Prostatic cancer and pelvic node involvement: a unambiguous disease?]
    Jean Louis Davin
    Prog Urol 16:239-56. 2006
  68. ncbi request reprint [Synthesis on the treatments of infiltrating tumors of the bladder]
    Olivier Bouchot
    Prog Urol 12:1143-57. 2002
  69. ncbi request reprint [Sarcomatoid carcinoma]
    Olivier Bouchot
    Prog Urol 12:1131-2. 2002
  70. ncbi request reprint [Conservative alternatives of bladder reservoir with more unusual indications]
    Olivier Bouchot
    Prog Urol 12:1043-56. 2002
  71. ncbi request reprint [Total cystectomy: surgical techniques]
    Marc Zerbib
    Prog Urol 12:833-56. 2002
  72. ncbi request reprint [Simultaneous combined radiotherapy and chemotherapy]
    Marc Zerbib
    Prog Urol 12:1019-42. 2002
  73. ncbi request reprint [Metastatic or locally advanced tumors of the bladder: is there a role for adjuvant surgery in chemotherapy?]
    Olivier Bouchot
    Prog Urol 12:999-1001. 2002
  74. ncbi request reprint [Neo-adjuvant and adjuvant chemotherapy in radical treatment]
    Olivier Bouchot
    Prog Urol 12:987-97. 2002
  75. ncbi request reprint [Fortuitous disclosure of prostatic cancer after examination of the cystoprostatectomy specimen]
    Marc Zerbib
    Prog Urol 12:957-60. 2002
  76. ncbi request reprint Stripping technique for endoscopic management of distal ureter during nephroureterectomy: experience of 32 procedures
    Bertrand Giovansili
    Department of Urology, Cochin Hospital, Paris, France
    Urology 64:448-52; discussion 452. 2004
    ..To assess the results of the stripping technique for endoscopic management of the distal ureter during nephroureterectomy...
  77. ncbi request reprint Will robotic surgery become the gold standard for radical prostatectomy?
    Aurelien Descazeaud
    Eur Urol 51:9-11. 2007